The crosstalk between osteodifferentiating stem cells and endothelial cells promotes angiogenesis and bone formation by Genova, T. et al.
Frontiers in Physiology | www.frontiersin.org 1 October 2019 | Volume 10 | Article 1291
BRIEF RESEARCH REPORT




University of Calabria, Italy
Reviewed by: 
Vincenzo Lionetti, 
Sant’Anna School of Advanced 
Studies, Italy
Akishige Hokugo, 
University of California, Los Angeles, 
United States
Ernestina Marianna De Francesco, 





†These authors have contributed 
equally to this work
Specialty section: 
This article was submitted to 
Vascular Physiology, 
a section of the journal 
Frontiers in Physiology
Received: 11 June 2019
Accepted: 25 September 2019
Published: 14 October 2019
Citation:
Genova T, Petrillo S, Zicola E, Roato I, 
Ferracini R, Tolosano E, Altruda F, 
Carossa S, Mussano F and Munaron L 
(2019) The Crosstalk Between 
Osteodifferentiating Stem Cells and 
Endothelial Cells Promotes 
Angiogenesis and Bone Formation.
Front. Physiol. 10:1291.
doi: 10.3389/fphys.2019.01291
The Crosstalk Between 
Osteodifferentiating Stem Cells  
and Endothelial Cells Promotes 
Angiogenesis and Bone Formation
Tullio Genova1,2*†, Sara Petrillo3†, Elisa Zicola4, Ilaria Roato5, Riccardo Ferracini6, 
Emanuela Tolosano3, Fiorella Altruda3, Stefano Carossa2, Federico Mussano2† and 
Luca Munaron1†
1 Department of Life Sciences and Systems Biology, UNITO, Turin, Italy, 2 Department of Surgical Sciences, CIR Dental 
School, UNITO, Turin, Italy, 3 Department of Molecular Biotechnology and Health Sciences, UNITO, Turin, Italy, 4 Department 
of Clinical and Biological Sciences, UNITO, Orbassano, Italy, 5 Center for Research and Medical Studies, A.O.U. Città della 
Salute e della Scienza, Turin, Italy, 6 Department of Surgical Sciences (DISC), Orthopaedic Clinic-IRCCS A.O.U. San Martino, 
Genoa, Italy
The synergistic crosstalk between osteodifferentiating stem cells and endothelial cells 
(ECs) gained the deserved consideration, shedding light on the role of angiogenesis for 
bone formation and healing. A deep understanding of the molecular basis underlying the 
mutual influence of mesenchymal stem cells (MSCs) and ECs in the osteogenic process 
may help improve greatly bone regeneration. Here, the authors demonstrated that 
osteodifferentiating MSCs co-cultured with ECs promote angiogenesis and ECs recruitment. 
Moreover, through the use of 3D co-culture systems, we showed that ECs are in turn able 
to further stimulate the osteodifferentiation of MSCs, thus enhancing bone production. 
These findings highlighted the existence of a virtuous loop between MSCs and ECs that 
is central to the osteogenic process. Unraveling the molecular mechanisms governing the 
functional interaction MSCs and ECs holds great potential in the field of regenerative medicine.
Keywords: mesenchymal stem cells, adipose-derived stem cells, bone vascularization, endothelial cells, 
co-culture, 3D cultures
BACKGROUND
Bone formation and remodeling require different cell populations to cooperate so as to regenerate 
a complex 3D tissue under the guidance of chemical and mechanical cues (Genova et  al., 
2016). Angiogenesis, the formation of new blood vessels from existing ones, is essential for 
bone formation and remodeling. The progressive substitution of an avascular cartilage template 
by a highly vascularized bone tissue is the characterizing feature of endochondral ossification. 
Likewise, during the fracture healing, which was classically thought to recapitulate the ontogenesis 
of the tissue (Urist, 1997), angiogenesis precedes osteogenesis and determines its efficiency. 
The crucial role of vascularization in bone tissue emerges also experimentally from the analysis 
of genetic models with bone defects, which have indeed been associated to defective vascularization 
(Schipani et  al., 1997; Vu et  al., 1998). Achieving the desired synergistic crosstalk between 
osteoblast precursors and endothelial cells is also crucial for implementing bone tissue engineered 
therapies based on the mutual influence of osteogenic and angiogenic cues.
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Thus, ensuring proper vascularization is mandatory for bone 
formation, remodeling, and reconstruction (Correia et al., 2011; 
Genova et al., 2016). Notwithstanding the acknowledged centrality 
of angiogenesis in bone development, as well as in graft survival 
after implantation (Griffith and Naughton, 2002), the molecular 
mechanisms driving vascularization in bone formation and 
remodeling are still poorly elucidated (Schipani et  al., 2009). 
Thus, a better comprehension of the molecular physiology 
underlining the crosstalk between osteodifferentiating stem cells 
and endothelial cell should be  sought.
A robust scientific evidence supports that endothelial cells 
enhance the osteogenic differentiation of mesenchymal stem 
cells (MSCs) in vitro and in vivo (Guillotin et  al., 2004; 
Leszczynska et  al., 2012; Zhang et  al., 2012; Liu et  al., 2013). 
According to equally compelling findings, murine periosteal-
derived MSCs promote survival and proliferation of human 
umbilical vein endothelial cells (HUVECs) through the 
production of VEGF in vitro and enhance in vivo vasculogenesis 
by resuming a pericyte-like phenotype able to support blood 
vessels (Van Gastel et  al., 2012).
In this work, adipose-derived stem cells (ASCs) (Zuk et  al., 
2001, 2002) have been used as a valuable model to investigate 
osteodifferentiation. Indeed, ASCs represent an abundant source 
of MSCs that are easily accessible and can be induced to differentiate 
in osteoblasts. Consistently, ASCs have been employed successfully 
to colonize bone graft before their surgical placement, in clinical 
protocols (Dufrane, 2017). The aim of the present study was to 
evaluate the functional biological effects of the interaction between 
osteodifferentiating ASCs and human microvascular endothelial 
cells (HMECs) as well as to unveil the complex crosstalk 
mechanisms that take place in the co-culture context.
MATERIALS AND METHODS
Cell Culture
Two cell types were used: human microvascular dermal 
endothelial cells (HMECs) and adipose-derived stem cells (ASCs).
HMECs were purchased from Lonza (Lonza, Switzerland) 
and were grown in complete EndoGRO-MV (Millipore, Italy) 
supplemented with 50  μg/ml gentamicin (Cambrex).
ASCs were isolated from patients who underwent orthopedic 
treatment with adipose tissue for knee osteoarthritis and signed 
informed consent, according to the Local Independent Ethics 
Committee permission (IRB), as previously described (Roato 
et al., 2019). Briefly, adipose tissue was digested with collagenase 
NB4 (SERVA Electrophoresis), subsequently washed with saline 
solution, treated with a cell lysis solution (Promega) to discard 
blood cells, and then cells were collected and counted. The 
purity of isolated ASCs was evaluated by flow cytometry, soon 
after isolation (Zuk et  al., 2001; Roato et  al., 2018).
Flow Cytometry Analysis of Mesenchymal 
Stem Cells Phenotype
ASCs were maintained in culture for two passages, then the 
following staining procedure was performed with monoclonal 
antibodies (moAb) fluorocrome-coniugated and isotypic controls: 
human CD105 PE (Invitrogen), CD73 FITC (kindly provided 
by Prof. Malavasi, University of Turin), CD44 FITC, CD45 
PerCP, IgG1 PE, IgG1 APC and IgG2a PerCP (Miltenyi Biotech), 
CD90 PerCP (Biolegend), and IgG1 FITC (Immunostep). About 
105 events/sample were used for capture with CellQuest software. 
Data were analyzed with Flowlogic software (Miltenyi Biotec).
To evaluate the morphology, cells were stained with 
Rhodamine-Phalloidin and DAPI after incubation in PBS 
containing 0.3% Triton X-100.
Osteogenic Cell Differentiation
To obtain osteogenic differentiation, 10 × 104/well ASCs were 
cultured in a six-well plate in osteogenic medium (OM) for 
7  days by supplementing the normal growth medium with 
10 mM β-glycerophosphate, 50 μg/ml ascorbic acid, and 0.02 mg/
ml dexamethasone. Prior to experiment, dexamethasone was 
removed in order to avoid any inhibitor effect on endothelial 
cells as reported in literature (Mussano et  al., 2017a).
Co-cultures
For co-cultures, transwell inserts 0.4  μm pore PC membrane 
(Transwell, Corning, USA) were used.
For migration, proliferation and tubulogenesis assays, ASCs 
(2 × 104 cells/ml) were seeded into 24-well transwell inserts (upper 
chamber) and HMECs were seeded into 24-well plates (bottom).
For qRT-PCR analysis, 10 × 104 HMECs were seeded into 
six-well 0.4  μm pore inserts, whereas ASCs were seeded into 
six-well plates (bottom), thus ensuring proper RNA extraction 
from ASCs.
Proliferation
Cells were plated at a density of 2,500 cells/well in 24-well 
culture dishes, and the proliferation was assessed by cell 
count and CellTiter-Glo® (Promega, Milan, Italy) according 
to the manufacturer’s protocol at 1, 3, and 7  days (Canullo 
et  al., 2017b; Mussano et  al., 2017b,c). This Luminescent 
Cell Viability Assay is a homogeneous method of determining 
the number of viable cells in culture based on quantitation 
of the ATP present. The amount of ATP is directly proportional 
to the number of viable cells in culture (as reported by 
the manufacturer).
Migration Assay
Cell motility was investigated as migration of cells into a wound 
introduced in a confluent monolayer. 4 × 104 HMECs were 
seeded in two chamber cell culture silicone inserts (Ibidi, 
Germany) for 24 h (after cell attachment, the insert is removed 
and a cell-free gap is created).
Cells did not undergo any significant degree of mitosis during 
the experiments. Experiments were done using a Nikon Eclipse 
Ti-E microscope with a 4X objective. Cells were kept at 37°C 
and 5% CO2 for all experiments, acquisition was obtained 
through Metamorph software (Molecular Devices, Sunnyvale, 
California, USA) (Avanzato et al., 2016; Canullo et al., 2016, 2017a). 
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Cell motility into a wound was measured with Metamorph 
software and was expressed as percentage of cell migration 
(Fiorio Pla et  al., 2010, 2014; Basilico et  al., 2015). At least 
three fields for each condition were analyzed in each independent 
experiment. At least three independent experiments were 
performed for each experimental condition.
Chemotaxis Assay
HMECs were seeded into Transwell inserts with 8 μm pore 
(0.5 × 104/transwell) and maintained in EndroGRO. The following 
day, transwells with HMECs were put into a 24-well plate 
(bottom chamber) with ASCs maintained in GM or OM. After 
4 h, transwell inserts were fixed with 4% paraformaldehyde 
and stained with DAPI. Non-migrated cells were removed using 
a cotton swab. Total migrated cells (nuclei) were counted.
In vitro Angiogenesis Assay
In vitro formation of capillary-like structures was performed 
on growth factor-reduced Matrigel (Corning, USA) in 24-well 
plates. Cells (3.5 × 104 cells/well) were seeded on the Matrigel 
and maintained in EndoGRO-MV. Cell organization in Matrigel 
was acquired after 10 h with a Nikon Eclipse Ti E microscope 
using a Nikon Plan 10X/0.10 objective. At least three 
independent experiments were done for each experimental 
condition (Genova et  al., 2017).
With ImageJ’s Angiogenesis Analyzer tool of Gilles Carpentier 
several parameters were analyzed:
 1. nodes are pixels with three neighbors represented as a 
circular dot;
 2. junctions correspond to nodes or group of fusing nodes;
 3. segments are elements delimited by two junctions;
 4. isolated elements are binary lines which are not branched;
 5. master segments consist in pieces of tree delimited by two 
junctions none exclusively implicated with one branch, called 
master junctions; and
 6. master junctions are junctions linking at least three master 
segments. Optionally, two close master junctions can be fused 
into a unique master junction.
With the word “tree,” we  identify the complex structure 
made of nodes and segments that endothelial cells form in 
vitro during this experiment.
RNA Extraction and Real-Time Polymerase 
Chain Reaction Analysis
Total RNA was extracted using PureLink RNA Mini Kit (Ambion, 
Life Technologies Italy). For quantitative real-time polymerase 
chain reaction (qRT-PCR), 1  μg total RNA was transcribed 
into complementary DNA by MultiScribe® Reverse Transcriptase 
(High-Capacity cDNA Reverse Transcription Kit, Thermo Fisher 
Scientific), and PCR analysis was then assessed using TaqMan 
probes from Roche. Transcript abundance, normalized to 18  s 
mRNA expression, is expressed as a fold increase over a 
calibrator sample. qRT-PCR was performed on a 7900HT Fast 
Real-Time PCR System (Applied Biosystems, Life Technologies 
Italy) (Herrera Sanchez et  al., 2017; Ingoglia et  al., 2017; 
Beneduce et al., 2019). Specific primers and probes were designed 
using the Universal Probe Library–Assay Design Center–Roche 
Life Science software1.
qRT-PCR primers:
 1. ANG1: gacagatgttgagacccaggta tctctagcttgtaggtggataatgaa
 2. ANG2: tgcaaatgttcacaaatgctaa aagttggaaggaccacatgc
 3. VEGF-A: ctacctccaccatgccaagt ccatgaacttcaccacttcgt
 4. PDGF-β: tgatctccaacgcctgct tcatgttcaggtccaactcg
 5. TGF-β: actactacgccaaggaggtcac tgcttgaacttgtcatagatttcg
 6. FGF-2: ttcttcctgcgcatccac ttctgcttgaagttgtagcttgat
 7. BMP-2: gactgcggtctcctaaaggtc ggaagcagcaacgctagaag
 8. OPN: gagggcttggttgtcagc caattctcatggtagtgagttttcc
Bioreactor and Scaffolds
About 7 mm heterologous cancellous bone matrix disks (Sp-Block, 
Tecnoss, Italy) were used as bone scaffolds and ASCs and 
HMEC were seeded (simultaneously in the co-culture condition).
In order to obtain a proper cell growth on bone scaffolds, 
the LiveBox2 bioreactor (IVTech, Italy) was used (Cacopardo 
et  al., 2019). The bioreactor is composed of a peristaltic pump, 
a reservoir, and a perfusion chamber. The perfusion chamber 
(which is composed of two chambers separated by a porous 
membrane) was used in a sigmoidal flux mode. This configuration 
determines a cell culture media flux from the upper chamber 
to the lower chamber, allowing a proper scaffold perfusion. 
The bioreactor was kept under a humidified atmosphere of 
5% CO2 in air, at 37°C using a 0.5  ml/min flux.
X-Ray Microtomography
Bone scaffolds were analyzed by high-resolution X-ray 
microtomography (SkyScan 1172, Bruker) to study the new 
bone formation as described in a previous work (Roato et  al., 
2018). (80  kV using a 0.5  mm Al filter at a resolution of 
6 μm, 0.4° of rotation step, 360° scan, and 4X frame averaging). 
A color contrast mask was used to allow a clear identification 
of newly formed mineralized tissue. The quantification of bone 
was performed by measuring the mineralized tissue length by 
using DataViewer software (Bruker).
Statistical Analysis
In vitro angiogenesis images were analyzed with the plug-in 
Angiogenesis Analyzer of ImageJ (Wayne Rasband, NIH, U.S.A.).
Data were analyzed by GraphPad Prism7 (GraphPad Software, 
Inc., La Jolla, USA) and Microsoft Excel. Each experiment 
was repeated at least three times. Statistical analysis was 
performed by using the Mann-Whitney non-parametric test 
or two-way ANOVA with Tukey’s multiple comparisons test. 
A p <0.05 was considered significant.
qRT-PCR data were analyzed by performing ordinary two-way 
ANOVA with Sidak’s multiple comparisons test for grouped 
analyses or Mann-Whitney test for column analyses.
1 www.lifescience.roche.com
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RESULTS
Characterization and Osteodifferentiation 
of Adipose-Derived Stem Cells
The purity of the isolated ASCs was assessed through flow 
cytometry analysis. In Figure 1A, a homogeneous cell population 
expressing mesenchymal markers is evident, showing a high 
expression of cells positive for CD105, CD44, CD90, CD73 
and negative for CD45 (Figures 1B–F). The morphology of 
ASCs (Figure 1G) well resembled the typical one of other 
stem cells obtained, e.g., from bone marrow or umbilical cord 
blood. Successively, we  investigated the ability of ASCs to 
undergo osteodifferentiation in culture with the 
osteodifferentiating medium (OM). As shown in Figures 1H,I, 
the OM enhanced the production of Runt-related transcription 
factor 2 (RUNX2) and Collagen type 1, key markers of 
osteodifferentiating cells. Consistently, after 7  days of 
osteodifferentiation, also the level of Alkaline phosphatase (ALP) 
activity was significantly increased compared to undifferentiated 
ASCs (Figure 1J).
Osteodifferentiating Adipose-Derived 
Stem Cells Promote Proliferation, 
Migration, and Vessel Recruitment of 
Human Microvascular Endothelium
In order to evaluate the biological effects of osteofferentiating ASCs 
on co-cultured endothelial cells, an ATP-based proliferation assay 
and a cell count were performed after 24 h of co-culture. As shown 
in Figures 2A,B, the presence of ASCs significantly increased the 
level of HMECs proliferation, regardless of osteodifferentiation. Next, 
the ability of ASCs to recruit microvascular endothelium was tested 
by performing a chemotaxis-based assay. Osteodifferentiating ASCs 
(Figure 2G) showed a significantly increased ability to attract 
endothelial cells when compared to undifferentiated ASCs. Endothelial 
cell migration is an essential step in bone tissue remodeling and 
vascularization. To understand how the differentiation of ASCs 
affects endothelial migration, a co-culture migration assay was 
performed in the presence of HMECs. Endothelial cells displayed 
a significantly enhanced migratory potential when co-cultured with 
osteodifferentiating ASCs. Conversely, undifferentiated ASCs did not 






FIGURE 1 | Characterization adipose-derived stem cells. (A–F) Flow cytometer analysis performed on in vitro cultured ASCs; the expression of CD105, CD44, 
CD90, CD73 (B–E) and the absence of CD45 (F) is shown. (G) Morphology of isolated ASCs, stained by phalloidin(red) and Dapi (Blue). (H,I) Real-time PCR 
analysis of RUNX2 and Coll-I expression in ASCs after 7 days of culture in osteogenic medium (OM) or growth medium (GM). Data represent mean ± SEM. 
*p < 0.05. (J) Alkaline phosphatase (ALP) activity in ASCs after 7 days of culture in OM or GM.
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Osteodifferentiating Adipose-Derived 
Stem Cells Increase in vitro Angiogenesis
During bone tissue formation, vascular endothelium migrates and 
forms a network of small capillaries to provide oxygen and nutrients 
to the newly formed tissue. For this reason, in vitro HMEC 
angiogenesis was evaluated to understand how this process is 
modulated by ASCs (Figure 3). HMECs were co-cultured with 
either osteodifferentiating ASCs or non-osteoinduced ASCs, in a 
tubulogenesis assay in vitro. A complete characterization of the 
complexity of the newly formed capillary network (in terms of 
number of nodes, number of master junctions, number of segments, 







FIGURE 2 | Biological effects induced by ASCs on co-cultured endothelial cells. (A) ATP-based proliferation assay performed on HMECs upon 24 h of co-culture 
with ASCs. (B) Cell count (DAPI staining) proliferation assay. (C–F) Migration assay performed on HMECs alone (CTRL) or upon co-culture with ASCs maintained in 
growth medium (GM) or osteodifferentiating medium (OM). (C–E) Representative picture of wound healing assay. (F) Quantification of endothelial cells migration in 
the indicated co-culture conditions. Data represent migration rate of HMEC after 8 h. (G) Chemotaxis assay performed on HMECs. The symbol (*) indicates 
statistical significance of ASC OM or ASC GM compared to the control condition (without ASCs) considering a p <0.05. The symbol (#) indicates statistical 
significance of ASC OM compared to ASC GM considering a p <0.05. CTRL, HMEC without ASCs; ASC GM, HMEC in co-culture with undifferentiated ASC; ASC 
OM, HMEC in co-culture with osteodifferentiating ASC.
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and total master segments length) is shown in Figure 3. The first 
three parameters represent the complexity of the interconnections 
inside the network; the last three are a measure of the capillary 
network extension in space. The capillary network shows higher 
complexity when HMECs were co-cultured with osteodifferentiating 




FIGURE 3 | Evaluation of the angiogenic potential of HMECs in the presence of ASCs. (A–F) Representative pictures of in vitro tubulogenesis assay performed on 
endothelial cells alone (CTRL) or upon co-culture with ASCs. The formation of capillary-like structures was performed on Matrigel coating and analyzed after 8 h 
using ImageJ’s Angiogenesis Analyzer tool. The quantification of main parameters describing the capillary network complexity is reported in (G) CTRL, HMECs 
without ASCs; ASCs GM, HMECs co-cultured with undifferentiated ASCs; ASCs OM, HMECs co-cultured with osteodifferentiating ASCs. The symbol (*) indicates a 
statistical significance vs. the CTRL condition; the symbol (#) indicates a statistical significance of the ASCs GM condition compared to ASCs OM condition, 
considering a p < 0.05.
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Endothelial Cells Induce the Release of 
Pro-angiogenic Factors by Adipose-
Derived Stem Cells and Promote Their 
Osteodifferentiation
As stated above, osteodifferentiating ASCs can increase the 
recruitment of endothelial cells and enhance angiogenesis. To 
investigate the molecular mechanisms underlying these biological 
effects, we  studied the expression profile of pro-angiogenic 
factors released by osteodifferentiating ASCs compared to 
undifferentiated ASCs. As shown in Figure 4A, the expression 
of key pro-angiogenic genes as Angiopoietin 1 (ANG-1), 
Angiopoietin 2 (ANG-2), vascular endothelial growth factor 
(VEGF), platelet-derived growth factor b (PDGFb), transforming 
growth factor b (TGFb), and basic fibroblast growth factor 
(FGF-2) is higher in osteodifferentiating ASCs (gray bars) 
compared to undifferentiated ASCs (black bars). These data 
indicate that osteodifferentiating ASCs release pro-angiogenic 
factors, thus enhancing angiogenesis.
To investigate whether the presence of endothelial cells may 
increase the ability of osteodifferentiating ASCs to promote 
angiogenesis, we performed the same gene expression screening 
in ASCs upon co-culture with HMECs. Importantly, the presence 
of endothelial cells can further enhance the production of 
some pro-angiogenic factors (i.e., VEGF, PDGFb, and FGF2) 
in osteodifferentiating ASCs compared to the basal condition 
(without endothelial cells) (Figure 4A).
Finally, we  evaluated the effects of the interaction between 
ASCs and endothelial cells in the process of osteodifferentiation. 
To this aim, we  analyzed the expression of osteogenic markers 
like bone morphogenetic protein 2 (BMP-2) and osteopontin 
(OPN) (Figure 4A). Importantly, the presence of endothelial 
cells can strongly increase the expression of both BMP-2 and 
OPN in osteodifferentiating ASCs. Taken together, these data 
highlight a complex crosstalk in which osteodifferentiating ASCs 
produce higher amount of pro-angiogenic factors, and endothelial 
cells in turn are able to promote the osteodifferentiation of ASCs.
Endothelial Cells Increase Bone 
Production in vitro
To test the ability of endothelial cells to stimulate bone formation, 
we  co-cultured HMECs and ASCs in a 3D in vitro model. A 
bone scaffold was maintained in a perfused bioreactor (LB2 
IVTech) to obtain a more reliable and physiological environment. 
To evaluate the bone production within the scaffold, we measured 
the newly formed trabeculae after 1 month of culture, using 
micro-tomography (Figure 4B). Notably, we  found that the 
presence of endothelial cells strongly increases bone production 
by ASCs.
This result supports the crucial role of endothelial cells in 
the process of osteodifferentiation of ASCs.
DISCUSSION
A strong crosstalk between osteoprogenitors and the vascular 
network underlies the processes of bone formation, remodeling, 
and healing. For this reason, endothelial cell recruitment and 
organization becomes paramount to all these processes (Carano 
and Filvaroff, 2003; Jain, 2003; Hankenson et  al., 2011). Thus, 
the co-culture condition was selected as the in vitro context closest 
to the physiological condition and the most suitable to unveil 
the mutual influence of osteodifferentiating cells and endothelial 
cells. To induce osteodifferentiation, ASCs were maintained for 
7 days in the traditional osteoinducing culture medium (OM) 
containing dexamethasone. This time window allowed achieving 
early osteodifferentiation meanwhile avoiding the loss of stemness 
features in the untreated counterpart. During co-culture 
experiments, the differentiation medium was deprived of 
dexamethasone to avoid a negative bias in endothelial cells response 
possibly deriving from the anti-angiogenic effects of this synthetic 
glucocorticoid (Heffernan et  al., 1978; Mirabelli et  al., 2014).
Our data collectively demonstrate that pre-osteodifferentiated 
ASCs promote endothelial cell recruitment and enhance their 
functionality, thus providing potential benefits in the 
clinical outcome.
The numerous advantages deriving from the use of ASCs 
co-cultures for the treatment of bone defects have already been 
reported. For instance, ceramic scaffolds containing both ASCs 
and bone marrow stromal cells (BMSCs) has proved more 
effective for the treatment of calvarial defects in mice compared 
to ceramic plus ASCs alone (Kim et  al., 2014).
To our knowledge we  showed, for the first time, that 
osteodifferentiating ASCs enhance the response of HMECs in 
terms of migration, recruitment, and the ability to form capillary-
like structures in vitro.
To quantify the angiogenic effect induced by the co-culture, 
some key descriptors of the capillary network complexity were 
considered, following established protocols (Petrillo et al., 2018). 
In particular, the number of nodes, master segments, and 
master junctions may suggest how the network is organized 
in terms of interconnection and progress toward intensification, 
which ultimately translates into a better vascularization. On 
the other hand, the parameter representing the total length of 
the structure indicates how the network tends to reach deeper 
into space, which translates into a more functional vascularization, 
an essential property of bone tissue. On the contrary, the 
number of isolated segments inversely correlates with a strong 
and complex vascularization: the higher the number of isolated 
segments, the weaker the network and the poorer its organization. 
All these parameters taken together, along with the chemotaxis 
and migration data, strongly support the enhanced response 
of endothelial cells due to the influence of osteodifferentiating 
ASCs compared to the undifferentiated counterpart.
In the present work, we  aimed to elucidate the putative 
paracrine factors responsible for the MSC-endothelial cells crosstalk 
occurring during osteogenic differentiation and vascular remodeling. 
Thus, we analyzed the expression of angiogenic and growth factors 
by ASCs in co-culture with or without endothelial cells. In 
particular, the mRNA levels of the main angiogenic and growth 
factors were detected through qRT-PCR in osteodifferentiating 
ASCs co-cultured with HMECs. We found that osteodifferentiating 
ASCs produced pro-angiogenic factors responsible for vessels 
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A
B
FIGURE 4 | (A) Expression profile of growth and angiogenic factors in co-cultured ASCs and HMECs. qRT-PCR analysis of growth and angiogenic factors performed 
on ASCs under basal conditions (without endothelial cells) or after 4 h of co-culture with HMECs. Undifferentiated (gray bar) and osteodifferentiating (black bar) ASCs 
are shown. Data represent mean ± SEM; n = 3. *p < 0.05; ** < 0.01; ***p < 0.001; ****p < 0.0001. Statistical analysis: ordinary two-way ANOVA with Sidak’s multiple 
comparisons test for grouped analyses. Ang1, Angiopoietin 1; Ang2, Angiopoietin 2; VEGF, vascular endothelial growth factor; PDGF-b, platelet-derived growth factor 
b; TGF-b, transforming growth factor b; FGF-2, basic fibroblast growth factor; BMP-2, bone morphogenetic protein 2; OPN, osteopontin. (B) Evaluation of bone 
formation by X-ray microtomography. Representative images of X-ray microtomography of bone scaffolds. ASCs were seeded in the bone scaffold and maintained in 
osteodifferentiating medium for 30 days. The experiment was performed in the presence (ASCs + HMEC) or not (ASCs basal) of endothelial cells. The bone scaffold is 
shown in blue, whereas the newly formed mineralized tissue is in red (indicated by white arrows). Quantification of the newly formed mineralized tissue for each 
experimental condition is reported in the histogram. ∗p < 0 05. CTRL, bone scaffold alone; ASCs GM (gray bar) cultured for 7 days in growth medium before being 
seeded in the bone scaffold; ASCs OM (black bar) cultured for 7 days in osteodifferentiating medium before being seeded in the bone scaffold.
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recruitment and angiogenesis. Importantly, the presence of 
endothelial cells further increased the release of pro-angiogenic 
factors by ASCs but also promoted the osteodifferentiation of 
ASCs, thus providing a virtuous loop of interaction.
These findings are in agreement with previous studies on 
3D-culture systems, showing that the co-culturing of ASCs 
with HUVECs increases the production of angiogenesis-related 
genes in both cell types and that these effects are mediated 
by the activation of Wnt/β-catenin pathway (Cai et  al., 2017).
In the present work, the pro-angiogenic factor VEGF-A was 
found up-regulated in ASCs upon co-culture with HMECs. The 
release of VEGF can trigger important responses in both ASCs 
and endothelial cells through a paracrine stimulation. For instance, 
VEGF has previously been reported to improve ASCs osteogenic 
differentiation (Clark et  al., 2015). Consistently, the expression 
level of the osteodifferentiation marker BMP-2 was higher when 
ASCs were co-cultured with HMECs. Originally described as the 
main player in the activation of the cascade of endochondral 
bone formation (Wozney et  al., 1988), BMP-2 is now recognized 
as a multi-purpose cytokine stimulating cell migration (Cunningham 
et al., 1992; Willette et al., 1999) and both osteoclasts and osteoblasts 
differentiation (Abe et  al., 2010). Notably, the production of 
pro-angiogenic factors as VEGF-A is actually stimulated by BMPs, 
particularly BMP-2/-4, as it has been shown in fracture-healing 
models in vivo (Suwa et al., 1998; Ripamonti et al., 2000; Moutsatsos 
et  al., 2001). Here, we  showed that enhanced angiogenesis is 
achieved through the production of osteoblast-derived angiogenic 
factors and osteodifferentiation is in turn increased by endothelial 
cells (Wang et al., 1997; Deckers et al., 2002). To further demonstrate 
the pivotal role of paracrine stimuli in the crosstalk between ASCs 
and ECs, it would be  of primary importance to directly measure 
the angiogenic and growth factors released by both cell types.
To overcome the classical limitations of traditional 2D culture 
systems, we  seeded ASCs in 3D bone scaffolds kept in a 
perfused millifluidic bioreactor. This model further supported 
the crucial role of endothelial cells in the process of bone 
formation. Indeed, the formation of bone trabeculae was strongly 
enhanced when ASCs where seeded in bone scaffolds in the 
presence of endothelial cells.
In recent years, great efforts have been made to improve 
bone regeneration techniques, owing not only to the technological 
innovations in the field of material science but also to a growing 
variety of sources of stem cells for autologous transplants 
(Derubeis and Cancedda, 2004; Correia et  al., 2014).
Among all the possible choices, MSCs hold great potential 
for bone tissue engineering (Samsonraj et  al., 2017). In the 
present work, we  focused our attention on ASCs, which can 
be  easily isolated from the adipose tissue with very low risks 
of infection or pain (Mussano et  al., 2018).
The suitability of stem cells in bone tissue engineering 
depends both on their ability to differentiate into osteoblasts 
and on their paracrine effects (Frontiers in bioengineering and 
biotechnology). Nowadays, stem cells are mostly implanted as 
undifferentiated cells and bone-inducing factors are provided 
in  loco to drive the differentiation process (Chen et  al., 2019). 
This therapeutic approach, however, is not entirely free of risks 
(Skovrlj et  al., 2015).
Here, we compared the biological response of undifferentiated 
ASCs to that of pre-differentiated ASCs kept in OM for 7 
days, this time period of induction being the shortest capable 
to induce an early osteodifferentiation (Sabatino et  al., 2012; 
Hanley et  al., 2014). This study highlights the prevalent role 
of osteodifferentiating ASCs, compared to the less differentiated 
cells of the same lineage, in promoting endothelial remodeling 
required for efficient vascularization. Notably, osteodifferentiating 
ASCs trigger strong angiogenic responses on microvascular 
endothelial cells in terms of migration, recruitment and tubule 
formation. This evidence may support the use of ex vivo 
differentiated ASCs to accelerate bone regeneration in tissue 
engineering. To overcome the intrinsic limitations of in vitro 
studies, the next step would be  the use of scaffolds containing 
both ASCs and endothelial cells in pre-clinical models of 
bone defects in order to provide evidences of the clinical 
benefits deriving from these findings. In future studies, 
differentiated ASCs could be  injected in vivo to test their 
osteoblast identity and their actual ability to be  integrated in 
the host tissue without the risk of rejection or bone 
formation defects.
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